Life Sciences
HIMSS24
Dr. Colin Banas, CMO at DrFirst, discusses the company's medication adherence product. It uses AI to send texts that educate patients about medications and provides coupons and co-pay-assistance program information, if cost is an issue.
HIMSS24
The founder and president of Medonations, a Lebanese medication company, talks about the aftermath of the 2020 Beirut explosion and her medication-access relief efforts following the disaster.
European pharmacy experts, including leaders from Cleveland Clinic London and other organizations discuss Project Asclepius, a collaborative effort for digitizing pharmacy operations.
Ankit Gupta, Bicycle Health CEO and founder, discusses how the company helps formerly incarcerated individuals access buprenorphine monthly injections for opioid use disorder via the Federal Bureau of Prisons and residential reentry centers.
Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.
Anna Dover, director of product management at FDB, formerly First Data Bank, says drug-related clinical decision support alerts pose challenges for prescribers and pharmacists, but technology can optimize the process through refinement.
Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.
HIMSS23
Dr. Colin Banas, chief medical officer at DrFirst, discusses how his company uses AI to automate tasks such as processing prescription refills, which prevents medication errors and reduces clinicians' administrative burden.
HIMSS23
Anna Dover, director of product management at First Databank, discusses First Databank's medication decision support technology, which helps keep clinicians informed about prescription drug information without overwhelming them.
HIMSS23
Dr. Cecil Lynch, chief medical information officer at Accenture, discusses his upcoming HIMSS23 lecture on genomics' potential impact on patient care and the importance of examining genetic information and its relationship to comorbidities.